Adrenocortical Scintigraphy with 131I-6-Beta-Iodomethyl-NorchoIesterol (NP 59) in Bilateral Adrenocortical Carcinoma

Gloria Ruíz Hernández; F. J. C. Pallarés; A. R. Bartual; Susana Tenes Rodrigo; F. J. Ampudia-Blasco; C. R. de Ávila y Ávalos

doi:10.1055/s-0038-1632314

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1998; 37(04): 141-145
DOI: 10.1055/s-0038-1632314

Original Article

Schattauer GmbH

Adrenocortical Scintigraphy with ¹³¹I-6-Beta-Iodomethyl-NorchoIesterol (NP 59) in Bilateral Adrenocortical Carcinoma

Nebennierenrinden-Szintigraphie mit ¹³¹I-6-Beta-Iodomethyl-Norcholesterol (NP 59) bei Nebennierenrinden-Karzinom

Authors

Gloria Ruíz Hernández

¹Servei de Medicina Nuclear
F. J. C. Pallarés

¹Servei de Medicina Nuclear
A. R. Bartual

²Servei d’Endocrinología, Hospital Clínic Universitari de València, Spain
Susana Tenes Rodrigo

²Servei d’Endocrinología, Hospital Clínic Universitari de València, Spain
F. J. Ampudia-Blasco

²Servei d’Endocrinología, Hospital Clínic Universitari de València, Spain
C. R. de Ávila y Ávalos

¹Servei de Medicina Nuclear

Abstract

Summary

A case of a 49-year-old man suffering from bilateral adrenocortical carcinoma with local and secondary rapid progression is reported. The results of adrenocortical scintigraphy (NP 59) and histological findings allowed the diagnosis. This case report and a literature review showed the importance of using adrenocortical scintigraphy as a complementary imaging procedure of CT or MR images.

Zusammenfassung

Es wird über einen 49jährigen Mann berichtet, der an einem beidseitigen Nebenierenrinden-Karzinom mit schneller lokaler und sekundärer Progression leidet. Die Ergebnisse der Nebenierenrinden-Szintigraphie (NP 59) und Histologie ermöglichten die Diagnose. Dieser Fallbericht und ein Literaturüberblick zeigen die Bedeutung der Nebenierenrinden- Szintigraphie als ein zusätzliches bildgebendes Verfahren neben CT und NMR.

Keywords

Bilateral incidentaloma - adrenocortical scintigraphy (NP 59) - adrenocortical carcinoma

Schlüsselwörter

Beidseitiges Inzidentalom - Nebenierenrinden-Szintigraphie (NP 59) - Nebenierenrinden-Karzinom

Full Text

References

References
1 Dunnick NR. Hanson lecture. Adrenal imaging: current status. AJR – Am J Roentgenol 1990; 154: 927-36.
2 Francis IR, Gross MD, Shapiro B, Krobkin M, Quint LE. Integrated imaging of adrenal disease. Radiology 1992; 184: 1-13.
3 Chao CS, Zhou ZG, Liao EY. The diagnosis and management of adrenal “incidentalo- ma”. Chung Hua Nei Ko Tsa Chih 1994; 33: 395-7.
4 Gross MD, Shapiro B, Bouffard JA, Glazer GM, Francis IR, Wilton GP. et al. Distinguishing benign from malignant euadrenal masses. Rev. Ann Intern Med 1988; 109: 613-8.
5 Shapiro B, Fig LM, Gross MD, Khafagi F. Radiochemical diagnosis of adrenal disease. Crit Rev Clin Lab Sei 1989; 27: 265-98.
6 Francis IR, Smid A, Gross MD, Shapiro B, Naylor B, Glazer GM. Adrenal masses in oncologic patients: functional and morphologic evaluation. Radiology 1988; 166: 353-6.
7 Gross MD, Wilton GP, Shapiro B, Cho K, Samuels BI, Bouffard JA. et al. Functional and scintigraphic evaluation of the silent adrenal mass. J Nucl Med 1987; 28: 1401-7.
8 Ogita M, Oyama T, Onohara S, Nakabeppu Y, Mukai H, Abeyama K. et al. Magnetic resonance imaging of the adrenal gland. Nippon – Igaku – Hoshasen – Gakkai – Zasshi 1991; 51: 1431-41.
9 Ho YJ, Yang CF, Lee SK, Chen JH, Hung SW, Lee KR. MRI of adrenal tumors. Chung – Hua. I – Hsueh – Tsa – Chih – Taipei 1992; 49: 231-7.
10 Honda H, Onitsuka H, Naitou S, Murakami J, Araki A, Torii Y. et al. Role of MRI in diagnosis of adrenal tumors. Nippin – Igaku – Hoshasen – Gakkai – Zasshi 1991; 51: 617-25.
11 Gross MD, Shapiro B. Clinical review 50: clinically silent adrenal masses. J Clin Endocrinol Metab 1993; 77: 885-8.
12 Kao CH, Liao SQ, Wang SJ, Lin MS, Hsu CY, Lin WY. ¹³¹I NP-59 adrenal cortical scintigraphy in suspected primary aldosteronism. Kao – Hsiung – I – Hsueh – Ko – Hsueh – Tsa – Chih 1992; 8: 213-8.
13 Kazerooni EA, Sisson JC, Shapiro B, Gross MD, Driedger A, Hurwitz GA. et al. Diagnostic accuracy and pitfalls of (iodine-131) 6-beta-iodomethyl-19-norcho- lesterol (NP-59) imaging. J Nucl Med 1990; 31: 526-34.
14 Nakajo M, Nakabeppu Y, Yonekura R, Iwashita S, Goto T. The role of adrenocortical scintigraphy in the evaluation of unilateral incidentally discovered adrenal and juxta- adrenal masses. Ann Nucl Med 1993; 7: 157-66.
15 Ishimura J, Kawanaka M, Fukuchi M. Clinical application of SPECT in adrenal imaging with iodine-¹³¹ -6-beta-iodomethyl-19-norcholesterol. Clin Nucl Med 1989; 14: 278-81.
16 Tenenbaum F, Lumbroso J, Schlumberger M, Mure A, Plouin PF, Caillou B. et al. Comparison of radiolabeled octeotride and metaiodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med 1995; 36: 1-6.
17 Neumann DR, Basile KE, Bravo EL, Chen EQ, Go RT. Malignant pheochromocytoma of the anterior mediastinum: PET findings with (¹⁸F) FDG and 82 Rb. J Comput Assist Tomogr 1996; 20: 312-6.
18 Shulkin BL, Koeppe RA, Francis IR, Deeb GM, Lloyd RV, Thompson NW. Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG. Radiology 1993; 186: 711-5.
19 Shulkin BL, Wieland DM, Schwaiger M, Thompson NW, Francis IR, Haka MS. et al. PET scanning with hydroxyephedrine: an approach to the localization of pheochromocytoma. J Nucl Med 1992; 33: 1125-31.
20 Gross MD, Shapiro B, Francis IR, Bree RL, Korobkin M, McLeod MK. et al. Scintigraphy of incidentally discovered bilateral adrenal masses. Eur J Nucl Med 1995; 22: 315-21.